Selection from HEOR Bibliography

IMS logo
Search criteria
Condition: Hematology
 
Cost analysis of sequencing new agents for the treatment of chronic lymphocytic leukemia from the perspective of the Brazilian supplementary health system
Authors: Leandro Brust (1), Celso Arrais (2), Fabiano Pombo (3), Diego Kashiura (4), Pedro Vitor Pereira Lima (4), Ana Travassos (5), Rafael Silva (5), Straus Tanaka (5)
Affiliations: 1: Dasa, Rio Grande do Sul, Brasil; 2: Universidade Federal de São Paulo, São Paulo, SP, Brasil; 3: Américas Centro de Oncologia Integrado, Rio de Janeiro, RJ, Brasil; 4: IQVIA Real World Insights Brazil, São Paulo, SP, Brasil; 5: AbbVie Brasil, São Paulo, SP, Brasil.
Publications: 
J Bras Econ Saúde 2022;14(1):80-8
Document Types: , Article
Countries: , Brazil
Abstract: https://jbes.com.br/wp-content/uploads/2022/05/JBES_141_80-88.pdf
Condition Year Language Analysis type
, Health economics, Hematology 2022 Portuguese , Cost effectiveness
 
 
Predictors of iron‑deficiency anemia in primary care older adults: a real‑world European multi‑country longitudinal study
Authors: Vetrano DL, Zucchelli A, Marconi E, Levi M, Pegoraro V, Cataldo N, Heiman F, Cricelli C, Lapi F
Affiliations: Vetrano DL: Department of Geriatrics, Catholic University of Rome and IRCCS Fondazione Policlinico “A. Gemelli”, Rome, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy
Publications: 
Aging Clin Exp Res (2020). https://doi.org/10.1007/s40520-019-01454-6
Document Types: , Article
Countries: , Belgium, Germany, Italy, Spain
Abstract: https://link.springer.com/article/10.1007/s40520-019-01454-6
Condition Year Language Analysis type
, Hematology 2020 English , Epidemiological study, Retrospective database analysis
 
 
Évaluation de la population à risque d’hyperkaliémie
Authors: Gilles Berrut1 Anne-Sophie Boureau1 Laure de Decker1 Olivier Hanon2
Affiliations: 1 Pôle hospitalo-universitaire de gérontologie clinique, CHU Nantes, France 2 Hôpitaux universitaires Paris Centre, Service de gériatrie, Hôpital Broca, Université Paris-Descartes, Paris, France
Publications: 
10.1684/pnv.2020.0873
Document Types: , Article
Countries: 
Abstract: https://www.jle.com/fr/revues/gpn/e-docs/evaluation_de_la_population_a_risque_dhyperkaliemie__317258/article.phtml
Condition Year Language Analysis type
, Cardiovascular disease, Hematology 2020 French , Retrospective database analysis
 
 
Hospitalizations and outpatient vists (H&OV) in moderate and severe acute graft versus host disease (aGVHD) patients in Finland and Sweden
Authors: Itälä-Remes M1, Viayna E2, Nicklasson M3, Keränen M4, Thunström D5, Pfeiffer M5, Roset M2, Lara N2, Sabatelli L5
Affiliations: 1 Turku University Hospital, Finland 2 IQVIA, Real World Solutions, Barcelona, Spain 3 Sahlgrenska, University Hospital, Gothenburg, Sweden 4 Helsinki University Hospital, Finland 5 Incyte Biosciences International, Morges, Switzerland
Publications: 
ISPOR 2020 Annual European Congress. 14-18 November 2020. Milan, Italy
Document Types: , Poster
Countries: , Finland, Sweden
Abstract: x
Condition Year Language Analysis type
, Hematology, Transplant 2020 English , Population Based Study, Retrospective cohort analysis
 
 
Patient preferences, treatment satisfaction, and quality of life in newly diagnosed and relapsed/refractory multiple myeloma patients receiving injectable-containing or fully oral therapies: the EASEMENT study
Authors: Neil Rabin1, Rami Kotb2, Athanasios Zomas3, Alonso Fernandez-Nistal3, Rocco D’Ambrosio3, Nawal Bent-Ennakhil3, Montserrat Roset4, Ombretta Annibali5
Affiliations: 1 University College London Hospitals, London, and North Middlesex University Hospital, UK; 2 CancerCare Manitoba, Winnipeg, Manitoba, Canada; 3 Takeda Pharmaceuticals International AG, Zurich, Switzerland; 4 IQVIA, Barcelona, Spain; 5 Università Campus Bio-Medico di Roma, Rome, Italy
Publications: 
COMy (the 6th World Congress on Controversies in Multiple Myeloma), Virtual congress, 3-4 October 2020
Document Types: , Poster
Countries: , Canada, Italy, UK
Condition Year Language Analysis type
, Hematology, Oncology 2020 English , Population Based Study
 
 
Gender differences in determinants of iron-deficiency anemia: a population-based study conducted in four European countries
Authors: Levi M1, Simonetti M2, Marconi E2, Brignoli O3, Cancian M3, Masotti A4, Pegoraro V5, Heiman F5, Cricelli C3, Lapi F2
Affiliations: 1 Local Health Unit Tuscany Centre, Florence, Italy 2 Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy 3 Italian College of General Practitioners and Primary Care, Florence, Italy 4 Department of Transfusion Medicine, Pordenone, Italy 5 IQVIA, Milan, Italy
Publications: 
Annals of Hematology (2019) 98:15731582
Document Types: , Article
Countries: , Belgium, Germany, Italy, Spain
Condition Year Language Analysis type
, Hematology 2019 English , Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis
 
 
A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on Darzalex® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries
Authors: Mathieu Rosé, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi
Affiliations: IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK
Publications: 
Presented at ISPE’s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24–28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA.
Document Types: , Poster
Countries: , Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland
Abstract: https://www.coodoc.com/pages/p1822-Daratumumab-ICPE-2019
Condition Year Language Analysis type
, Hematology, Oncology 2019 English , Public Health, Survey research
 
 
The clinical and economic burden of cytomegalovirus management post allogeneic hematopoietic stem cell transplantation in Japan - a retrospective database study
Authors: Rie Ueno 1, Shinichi Nishimura 1, Go Fujimoto 1, Yi Piao 2, Katsuto Takenaka 3 (rwesheorj A)
Affiliations: 1) MSD K.K., Tokyo, Japan 2) IQVIA Solutions Japan K.K., Tokyo, Japan 3) Department of Hematology, Clinical Immunology and Infectious Diseases, Graduate School of Medicine, Ehime University, Toon, Japan
Publications: 
Current Medical Research and Opinion
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2019.1649379
Condition Year Language Analysis type
, Hematology 2019 English , Epidemiological study, Retrospective database analysis
 
 
Medication adherence/persistence and demographics of Japanese dyslipidemia patients on statin-ezetimibe as a separate pill combination lipid-lowering therapy- an observational pharmacy claims database study
Authors: Tatsuya Umeda 1, Ai Hayashi 1, Go Fujimoto 1, Yi Piao 2, Nobutomo Matsui 2, Shigeru Tokita 1
Affiliations: 1) Medical Affairs, MSD K.K. 2) Real World Insights, IQVIA Solutions Japan K.K.
Publications: 
Circulation Journal Circ J. 2019 Jul 25;83(8):1689-1697
Document Types: , Abstract, Article, Poster
Countries: , Japan
Abstract: https://www.jstage.jst.go.jp/article/circj/83/8/83_CJ-18-1344/_article
Condition Year Language Analysis type
, Hematology 2019 English , Epidemiological study, Retrospective database analysis
 
 
A budget impact analysis of anti-inhibitor coagulant complex use in pediatric hemophilia A patients with inhibitors across kingdom of Saudi Arabia
Authors: Al Jedai A1, AL-Mudaiheem H1, Al daamah S2, Al kasim F3, Wasri A4, Shaheen N5, Dawood E6, El-Hamaidi I7, Mohamed O8
Affiliations: 1Ministry of Health, Riyadh, NJ, USA, 2Ministry of Health, Damam, Saudi Arabia, 3Ministry of Health, Riyadh, Saudi Arabia, 4Ministry of National Guards, Jeddah, Saudi Arabia, 5King Faisal Specialized Hospitals, Damam, Saudi Arabia, 6Ministry of Health, Mekkah, Saudi Arabia, 7Ministry of National Guards, Riyadh, Saudi Arabia, 8IQVIA, Dubai, DU, United Arab Emirates
Publications: 
2019-11, ISPOR Europe 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Saudi Arabia
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3122/96011
Condition Year Language Analysis type
, Hematology, Rare disease 2019 English , Budget impact
 
 
Cost of treating iron deficiency anaemia (ida) with ferric carboxymaltose versus iron saccharate in heavy uterine bleeding (hub) patients in the kingdom of Saudi Arabia
Authors: A. Alhejazi1, O. Mohamed2, M. Alhowimel1, M. Al Adham1
Affiliations: Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia; IQVIA, Dubai, United Arab Emirates; Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia; Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia
Publications: 
DOI: https://doi.org/10.1016/j.jval.2019.04.824
Document Types: , Article
Countries: , Saudi Arabia
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)31016-2/abstract
Condition Year Language Analysis type
, Hematology, Womens Health 2019 English , Budget impact, Predictive analytics
 
 
Health economic value of blood in Ivory coast: The case of maternal bleeding
Authors: Sekongo YM1, Asamoah-Akuoko L2, Owusu-Ofori SPO3, Lamotte M4, Bah A5, Dierick K5
Affiliations: 1 DEA Biologie Humaine et Tropicale Unité de Thérapeutique Transfusionnelle Centre National de Tranfusion Sanguine DU de Biologie Transfusionnelle DU Gestion des infections et soins complementaires en Onco-Hématologie DU BIOSAS DU Reparation juridique du Do, Abidjan,Yvory Coast 2 National Blood Service, Accra, Ghana 3 Komfo Anokye Teaching Hospital, Kumasi, Ghana 4 IQVIA, Zaventem, Belgium 5 Terumo BCT, Zaventem, Belgium
Publications: 
ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: , Ivory Coast
Abstract: https://doi.org/10.1016/j.jval.2019.09.1429
Condition Year Language Analysis type
, Health economics, Hematology 2019 English , Cost analysis, Literature Review
 
 
Health economic vale of blood in Ghana: The case of maternal bleeding
Authors: Owusu-Ofori SPO1, Asamoah-Akuoko L2, Lamotte M3, Bah A4, Dierick K4
Affiliations: 1 Komfo Anokye Teaching Hospital, Kumasi, Ghana 2 National Blood Service, Accra, Ghana 3 IQVIA, Zaventem, Belgium 4 Terumo BCT, Zaventem, Belgium
Publications: 
ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: 
Abstract: https://doi.org/10.1016/j.jval.2019.09.1964
Condition Year Language Analysis type
, Health economics, Hematology 2019 English , Cost analysis, Survey research
 
 
Health economic value of blood in Sub-Saharan: The case of maternal bleeding
Authors: Owusu-Ofori SPO1, Sekongo YM2, Rajab JA3, Asamoah-Akuoko L4, Magutu V5, Lamotte M6, Bah A7, Dierick K7
Affiliations: 1 Komfo Anokye Teaching Hospital, Kumasi, Ghana 2 DEA Biologie Humaine et Tropicale Unité de Thérapeutique Transfusionnelle Centre National de Tranfusion Sanguine DU de Biologie Transfusionnelle DU Gestion des infections et soins complementaires en Onco-Hématologie DU BIOSAS DU Reparation juridique du Do, Abidjan, Yvory Coast 3 Haematology & Blood Transfusion Unit, Department of Human Pathology, School of Medicine, College of Health Sciences, University of Nairobi, Kenya 4 National Blood Service, Accra, Ghana 5 Department of Pathology Agar Khan Hospital, Nairobi, 110, Kenya 6 IQVIA, Zaventem, Belgium 7 Terumo BCT, Zaventem, Belgium
Publications: 
ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: 
Abstract: https://doi.org/10.1016/j.jval.2019.09.2059
Condition Year Language Analysis type
, Health economics, Hematology 2019 English , Cost analysis, Survey research
 
 
The value of blood in sub-Saharan Africa
Authors: Magutu V1, Rajab A2, Asamoah-Akuoko L3, Lamotte M4, Bah A5, Dierick K5
Affiliations: 1 Department of Pathology Agar Khan Hospital, Nairobi, 110, Kenya 2 Haematology & Blood Transfusion Unit, Department of Human Pathology, School of Medicine, College of Health Sciences, University of Nairobi, Nairobi, Kenya 3 National Blood Service, Accra, Ghana 4 IQVIA, Zaventem, Belgium 5 Terumo BCT, Zaventem, Belgium
Publications: 
ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: 
Abstract: https://doi.org/10.1016/j.jval.2019.09.2084
Condition Year Language Analysis type
, Health economics, Hematology 2019 English , Cost analysis, Survey research
 
 
Patient characteristics and treatment patterns in multiple myeloma by treatment administration route and disease status: EASEMENT observational study
Authors: Rabin N1, Kotb R2, Zomas A3, Gonzalez F3, Fernandez-Nistal A3, D’Ambrosio R3, Bent-Ennakhil N3, Roset M4, Annibali O5
Affiliations: 1 University College Hospital, London, UK 2 Cancer Care Manitoba, Canada 3 Takeda Pharmaceuticals International AG, Switzerland 4 IQVIA, Barcelona, Spain 5 Università Campus Bio-Medico di Roma, Italy
Publications: 
IMW, Boston, US, 12-15 September 2019
Document Types: , Poster
Countries: , Canada, Italy, UK
Abstract: https://doi.org/10.1016/j.clml.2019.09.456
Condition Year Language Analysis type
, Clinical practice, Hematology 2019 English , Epidemiological study, Observational study
 
 
Clinical characteristics, treatment patterns, and thromboembolic risk of patients with cold agglutinin disease (CAD) in Japan
Authors: Toyomi Kamesaki 1, Jun-ichi Nishimura 2, Hideho Wada 3, Eric Yu 4, Elisa Tsao 5, Jaime Morales 5, Yuzuru Kanakura 2 (rwesheorj 4)
Affiliations: 1) Jichi Medical University 2) Osaka University, Osaka, Japan 3) Kawasaki Medical School, Kurashiki, Japan 4) IQVIA, Tokyo, Japan 5) Sanofi, Waltham, MA, USA
Publications: 
European Hematology Association 2019 Conference
Document Types: , Abstract, Poster
Countries: , Japan
Abstract: https://library.ehaweb.org/eha/2019/24th/266231/jun-ichi.nishimura.clinical.characteristics.treatment.patterns.and.html
Condition Year Language Analysis type
, Hematology 2019 English , Epidemiological study, Retrospective database analysis
 
 
LIMITATIONS AND EXPECTED CHALLENGES OF CAR-T ECONOMIC EVALUATION.
Authors: Allou A*, Carette J*, Minacori R*, Touahmia S*, Bourguignon S*, Troubat A*, Maurel F*
Affiliations: IQVIA France - RWI
Publications: 
ISPOR 2018
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Comparative Effectiveness & Health Technology Assessment, Health economics, Hematology 2018 English , Cost effectiveness, Market impact, Review
 
 
Cost-utility analysis of life-long prophylaxis with recombinant factor VIIIFc vs recombinant factor VIII for the management of severe hemophilia A in Sweden.
Authors: Henry N1, Jovanović J1, Schlueter M1, Kritikou P2, Wilson K2, Myrén KJ2.
Affiliations: Henry N1, Jovanović J1, Schlueter M1, Kritikou P2, Wilson K2, Myrén KJ2. 1 IQVIA , London , UK. 2 Swedish Orphan Biovitrum AB , Stockholm , Sweden.
Publications: 
Document Types: , Article
Countries: , Nordic, UK
Condition Year Language Analysis type
, Hematology, Rare disease 2018 English , Retrospective database analysis
 
 
Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease
Authors: Peyrin-Biroulet L1, Van Assche G2, Gómez-Ulloa D3, García-Álvarez L3, Lara N3, Black CM4, Kachroo S4.
Affiliations: 1Gastroenterology Department, Lorraine University, Vandoeuvre, France. 2Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. 3IMS Health, Real-World Evidence Solutions, Barcelona, Spain. 4Center for Observational and Real-World Evidence (CORE), Merck and Co, Inc, Kenilworth, New Jersey.
Publications: 
: Clin Gastroenterol Hepatol. 2016 Jul 5. pii: S1542-3565(16)30372-X. doi: 10.1016/j.cgh.2016.06.025
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Gastrointestinal disorders, Hematology 2016 English , Review
 
 
Epidemiology of patients receiving hematopoietic stem cell patients in Belgium.
Authors: Chevalier P, Tsakeu E, Lamotte M
Affiliations: QuintilesIMS, Zaventem, Belgium
Publications: 
19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
Document Types: , Abstract
Countries: , Belgium
Condition Year Language Analysis type
, Hematology 2016 English
 
 
EQOFIX: a combined economic and quality-of-life study of hemophilia B treatments in France.
Authors: Polack B1, Calvez T2, Chambost H3, Rothschild C4, Goudemand J5, Claeyssens S6, Borel-Derlon A7, Bardoulat I8, Maurel F8, Woronoff-Lemsi MC9; EQOFIX Study Group.
Affiliations:  1Department of Hematology, University Hospital, and CNRS UMR5525, Grenoble-Alpes University, Grenoble, France. 2Sorbonne University, UPMC University of Paris 06, INSERM, UMR-S 1136, Pierre Louis Institute of Epidemiology and Public Health, Paris, France. 3APHM, Department of Pediatric Hematology, Children Hospital La Timone, and INSERM, UMR 1062, Aix-Marseille University, Marseille, France. 4Regional Hemophilia Center, Department of Hematology, University Hospital Necker Enfants Malades, Paris, France. 5Department of Hematology-Transfusion, University Hospital, Lille, France. 6Regional Hemophilia Center, Purpan Hospital, Toulouse, France. 7Regional Hemophilia and VWD Center, University Hospital, and INSERM U919, Caen, France. 8Department of Health Economics and Outcome Research, IMS Health, La Défense, France. 9Pharmacy, University Hospital, and INSERM UMR1098, Franche-Comté University, Besançon, France.
Publications: 
Transfusion (2015)
Document Types: , Article
Countries: , France
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/25652955
Condition Year Language Analysis type
, Hematology 2015 English , Economic evaluation, Observational study, Quality of life
 
 
Use of ADH antagonists results in lower hospital resource usage: a retrospective cohort study
Authors: Paul Grant 1 , Clare Jamookeeah 2 , Penny Dhanjal 2 & Gethin Griffith 2
Affiliations: 1Royal Sussex County Hospital, Brighton, UK; 2Otsuka Pharmaceuticals (UK) Ltd, Wexham, UK.
Publications: 
Endocrine Abstracts (2015) 38 P20 | DOI: 10.1530/endoabs.38.P20
Document Types: , Abstract
Countries: , UK
Abstract: https://www.endocrine-abstracts.org/ea/0038/ea0038p20
Condition Year Language Analysis type
, Guidelines, Hematology, Methodology 2015 English , Burden of illness, direct to patient research, Retrospective cohort analysis, Review
 
 
Diagnosis of pernicious anemia and the risk of pancreatic cancer.
Authors: Shah P, Rhim AD, Haynes K, Hwang WT & Yang YX
Affiliations: Memorial Sloan Kettering Cancer Center Department of Medicine, Gastroenterology and Nutrition Service
Publications: 
Pancreas. 2014 Apr;43(3):422-6. doi: 10.1097/MPA.0000000000000054
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015141/
Condition Year Language Analysis type
, Hematology, Oncology 2014 English , Retrospective database analysis
 
 
The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study
Authors: Donaldson JW, McKeever TM, Hall IP, Hubbard RB, Fogarty AW
Affiliations: University of Nottingham Division of Epidemiology and Public Health
Publications: 
Thorax. 2014 Feb;69(2):161-7. doi: 10.1136/thoraxjnl-2013-203720. Epub 2013 Nov 4
Document Types: , Abstract
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24188926
Condition Year Language Analysis type
, Hematology, Vascular disease 2014 English , Retrospective database analysis
 
 
Costes de los agentes estimulantes de la eritropoyesis en el tratamiento de la anemia inducida por quimioterapia en España: resultados preliminares procedentes de la adaptación de un estudio belga
Authors: Duran A1, Spaepen E2, Lamotte M3, Brosa M4, Gutiérrez L5, Restovic G6
Affiliations: 1IMS Health, London, 2SBD Analytics, Belgium, 3IMS Health, Belgium, 4Oblikue Consulting, Spain, 5Amgen SA, Spain, 6Independant Consultant, Spain
Publications: 
Pharmacoecon Span Res Artic (2014) 11:15–23
Document Types: , Article
Countries: , Spain
Abstract: https://link.springer.com/article/10.1007/s40277-013-0022-7
Condition Year Language Analysis type
, Hematology 2013 Spanish , Cost analysis
 
 
Cost-effectiveness of rivaroxaban for the treatment of pulmonary embolism and secondary prevention of venous thromboembolism – a UK perspective
Authors: McLeod E1, Guillermin A1, Hudson R1, Bamber L2, Muston D3, Lensing A2
Affiliations: 1IMS Health, London, United Kingdom, 2Bayer HealthCare Pharmaceuticals, Wuppertal, Germany, 3Bayer plc, Berkshire, United Kingdom
Publications: 
ISTH July 2013, The Netherlands
Document Types: , Abstract
Countries: , UK
Abstract: http://www.eventure-online.com/eventure/publicAbstractView.do?id=216996&congressId=6839
Condition Year Language Analysis type
, Hematology 2013 English , Cost effectiveness
 
 
Identification and qualitative assessment of real world data sources: example of lymphoma and multiple myeloma in Europe
Authors: Noibi S1, Bertwistle D1, MacDougall F1, Berger K2, Mehta J3, Trask P3
Affiliations: 1IMS Health, London, UK, 2IMS Health, Munich, Germany, 3Sanofi, Cambridge, MA, USA
Publications: 
ISPOR 16th Annual European Congress, 2013. PRM48.
Document Types: , Abstract, Poster
Countries: , Europe
Abstract: http://www.ispor.org/Events/Posters.aspx?eventId=42&sess=V
Condition Year Language Analysis type
, Hematology, Oncology 2013 English , Real World Data
 
 
Antithrombotic drugs and risk of hemorrhagic stroke in the general population.
Authors: García-Rodríguez LA, Gaist D, Morton J, Cookson C & González-Pérez A
Affiliations: Spanish Centre for Pharmacoepidemiological Research (CEIFE)
Publications: 
Neurology. 2013 Aug 6;81(6):566-74. doi: 10.1212/WNL.0b013e31829e6ffa. Epub 2013 Jul 10.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23843464
Condition Year Language Analysis type
, Cardiovascular disease, Hematology 2013 English , Retrospective database analysis
 
 
Investigation of the Effect of Deprivation on the Burden and Management of Venous Leg Ulcers: A Cohort Study Using the THIN Database.
Authors: Petherick ES, Cullum NA & Pickett KE.
Affiliations: Bradford Institute for Health Research
Publications: 
PLoS One 8(3):e58948 •DOI: 10.1371/journal.pone.0058948
Document Types: , Article
Countries: , UK
Abstract: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058948
Condition Year Language Analysis type
, Dermatology, Hematology 2013 English , Retrospective database analysis
 
 
Gilbert's syndrome and the risk of death: a population-based cohort study.
Authors: Horsfall LJ, Nazareth I, Pereira SP & Petersen I
Affiliations: UCL Research Department of Primary Care and Population Health
Publications: 
J Gastroenterol Hepatol. 2013 Oct;28(10):1643-7. doi: 10.1111/jgh.12279.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23701650
Condition Year Language Analysis type
, Hematology, Metabolic Disorders 2013 English , Retrospective database analysis
 
 
Signal Refinement of Drug-Induced Thrombocytopenia using The Health Information Network (THIN) Database.
Authors: Liu K, Hauben M & Bate A
Affiliations: Pfizer
Publications: 
29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Montreal, Canada
Document Types: , Poster
Countries: , UK
Abstract: http://csdmruk.cegedim.com/THINBibliography.pdf
Condition Year Language Analysis type
, Cardiovascular disease, Hematology 2013 English , Retrospective database analysis
 
 
Mortality after hemorrhagic stroke: data from general practice (The Health Improvement Network).
Authors: González-Pérez A, Gaist D, Wallander MA, McFeat G & García-Rodríguez LA
Affiliations: Spanish Centre for Pharmacoepidemiological Research (CEIFE)
Publications: 
Neurology. 2013 Aug 6;81(6):559-65. doi: 10.1212/WNL.0b013e31829e6eff. Epub 2013 Jul 10.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23843467
Condition Year Language Analysis type
, Cardiovascular disease, Hematology 2013 English , Retrospective database analysis
 
 
Health-related quality of life and annual direct medical costs of patients with haemophilia B in France : the EQOFIX study
Authors: Polack B 1, Calvez T 2, Claeyssens S 3, Chambost H 4, Derlon A 5, Goudemand J 6, Rotshild C 7, Maurel F 8, Woronoff-Lemsi MC 9
Affiliations: 1 Department of hematology, CHU Grenoble, Grenoble, France - 2 Inserm & UPMC, Paris, France - 3 Regional Haemophilia Treatment center, Toulouse, France - 4 Regional Haemophilia Treatment center, Marseille, France - 5 Regional Haemophilia Treatment center, Caen, France - 6 Regional Haemophilia Treatment center, Lille, France - 7 Regional Haemophilia Treatment center, Paris cedex 1, France - 8 IMS health, Puteaux, France - 9 Department of Pharmacy, Besançon, France
Publications: 
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Abstract, Poster
Countries: , France
Condition Year Language Analysis type
, Hematology 2012 English , Cost of illness, Prospective study, Quality of life
 
 
Hemoglobin Decline in Chemotherapy Patients Prior To and After Policy Changes Affecting Use of Erythropoiesis-stimulating Agents: 2006 - 2009
Authors: Hill JW1, Cong Z1, Hess G1, McGarvey N1, Nordyke RJ1
Affiliations: 1IMS Health, Plymouth Meeting, PA 19462, USA
Publications: 
J Int Med Res. 2012 ;40 (4):1532-45
Document Types: 
Countries: 
Condition Year Language Analysis type
, Hematology 2012 English , Burden of illness
 
 
Cost analysis: treatment of chemotherapy-induced anemia with erythropoiesis-stimulating agents in five European countries
Authors: Duran A1, Spaepen E2,Lamotte M3, Walter E4, Umuhire D5, Lucioni C6, Pinheir B7, Brosa M8, Pujol LKB9, Van Belle S10, Annemans L11
Affiliations: 1 IMS Health, London, UK 2 SBD Analytics BVBA/SPRL, Bekkevoort, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Institute for Pharmaeconomic Research, Health Economics, Vienna, Austria 5 IMS Health, Paris, France 6 Wolters Kluwer Health Italy, Milan, Italy 7 CISEP, Research Centre on the Portuguese Economy, Lisbon, Portugal 8 Oblikue Consulting, Barcelona, Spain 9 Amgen (Europe) GmbH, Zug, Switzerland 10 Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium 11 I-CHER, Ghent University, Brussels University (VUB), Ghent, Belgium
Publications: 
Journal of Medical Economics Vol. 15, No. 3, 2012, 1–10
Document Types: , Article
Countries: , Austria, Belgium, France, Italy, Spain
Condition Year Language Analysis type
, Hematology 2012 English , Cost analysis
 
 
Health economics analysis of pegfilgrastim in the prophylaxis of febrile neutropenia (FN) in Italy.
Authors: G. Rosti 1, M. Lebboroni 1, A. Cerchiari 2, P. Katz 3
Affiliations: 1 Ospedale Regionale Azienda Unità Locale Socio Sanitaria n°9 di Treviso, Oncologia Medica, Treviso, Italy 2 Amgen Dompè SpA, Health Economics, Milano, Italy 3 CSD Medical Research S.r.l, Pharmacoepidemiology & Health Economics, Milano, Italy
Publications: 
17th Congress of European Association of Hospital Pharmacists,
Document Types: , Poster
Countries: , Italy
Abstract: http://ejhp.bmj.com/content/19/2/172.2
Condition Year Language Analysis type
, Health economics, Hematology 2012 English , Budget impact
 
 
Hemoglobin Decline in Cancer Patients Receiving Chemotherapy Without An Erythropoiesis-Stimulating Agent
Authors: Pirker R1, Pirolli M2, Quigley J2, Hulnick S2, Legg J3, Collins H3, Vansteenkiste J4
Affiliations: 1 Medical University Vienna, Vienna, AT 2 IMS Health, USA (Formerly SDI Health) 3 Amgen, Inc., Thousand Oaks, USA
Publications: 
Support Care Cancer DOI 10.1007/s00520-012-1617-2. September 2012.
Document Types: , Article
Countries: , USA
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584249/
Condition Year Language Analysis type
, Hematology 2012 English , Burden of illness
 
 
Health-related quality of life and annual direct medical cost of patients with haemophilia B in France: the eqofix study.
Authors: Polack B1, Calvez T2, Chambost H3, Rothschild C4, Goudemand J5, Claeyssens S6, Borel-Derlon A7, Bardoulat I8, Maurel F8, Woronoff-Lemsi MC9
Affiliations: 1 Department of Hematology, University Hospital, and CNRS UMR5525, Grenoble-Alpes University, Grenoble, France 2 Sorbonne University, UPMC University of Paris 06, INSERM, UMR-S 1136, Pierre Louis Institute of Epidemiology and Public Health, Paris, France 3 APHM, Department of Pediatric Hematology, Children Hospital La Timone, and INSERM, UMR 1062, Aix-Marseille University, Marseille, France 4 Regional Hemophilia Center, Department of Hematology, University Hospital Necker Enfants Malades, Paris, France 5 Department of Hematology-Transfusion, University Hospital, Lille, France 6 Regional Hemophilia Center, Purpan Hospital, Toulouse, France 7 Regional Hemophilia and VWD Center, University Hospital, and INSERM U919, Caen, France 8 Department of Health Economics and Outcome Research, IMS Health, La Défense, France 9 Pharmacy, University Hospital, and INSERM UMR1098, Franche-Comté University, Besançon, France
Publications: 
ISPOR 15th Annual European Congress, 2012, 3-7 November, Berlin, Germany
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Hematology 2012 English , Clinical setting: hospital, Cost analysis, Observational study, Patient questionnaire, Prospective study, Quality of life
 
 
Cost and quality of life benefits of faster bleed resolution with an rFVIIa analogue: a mathematical simulation study for the German population.
Authors: Pokras SM. Petrilla AA. Weatherall J. Lee WC.
Affiliations: HEOR, IMS Consulting Group, USA; Novo Nordisk, Denmark
Publications: 
International Society for Pharmacoeconomics & Outcomes Research (ISPOR) 14th Annual European Congress, Madrid, Spain. November 7, 2011.
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Hematology 2011 English , Cost effectiveness, Economic evaluation
 
 
Verbrauch von Erythropoese-stimulierenden Faktoren in der Therapie der renalen Anämie: Analyse von Verordnungsdaten aus der Routineversorgung in Deutschland [Use of erythropoiesis-stimulating factors in the therapy of renal anemia: Analysis of prescription data of the German routine data]
Authors: Schöffski O1, Müller H-J2, Kostev K3, Claus V4
Affiliations: 1 Lehrstuhl für Gesundheitsmanagement Universität Erlangen-Nürnberg, Germany, 2 Medizinische Klinik III, Klinikum Fulda gAG, Germany, 3 IMS Health GmbH & Co. OHG, Munich, Germany, 4 IMS Health GmbH & Co. OHG, Frankfurt, Germany
Publications: 
Nieren- und Hochdruckkrankheiten 2011; 40(2):84-90
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Hematology, Nephrology 2011 German , Retrospective cohort analysis
 
 
The economics of inpatient on-demand treatment for haemophilia with high-responding inhibitors: a US retrospective data analysis
Authors: Pokras SM, Petrilla AA, Weatherall J, Lee WC.
Affiliations: IMS Consulting Group, USA. Novo Nordisk Denmark
Publications: 
Haemophilia
Document Types: , Article
Countries: , USA
Abstract: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2516.2011.02623.x/full
Condition Year Language Analysis type
, Hematology 2011 English , Retrospective database analysis
 
 
Synchronization of Administrations of Chemotherapy and Erythropoiesis-Stimulating Agents and Frequency of Associated Health Care Visits
Authors: Hill J1, Shreay S2, McGarvey N2, De AP1, Hess GP1, Corey-Lisle P2
Affiliations: 1IMS Health (formally SDI Health), Plymouth Meeting, PA, USA, 2Amgen, Inc., Thousand Oaks, CA, USA
Publications: 
Value in Health Volume 14, Issue 3 , Page A173, May 2011
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Clinical practice, Hematology 2011 English
 
 
Rate of hemoglobin decline in patients receiving chemotherapy without an erythropoiesis-stimulating agent in the United States community setting.
Authors: Pirolli M, Collins H2, Quigley J1, Hulnick S1
Affiliations: 1 IMS Health, USA (Formerly SDI Health) 2 Amgen, Inc., Thousand Oaks, USA
Publications: 
European Journal of Cancer, 2011
Document Types: , Abstract
Countries: , USA
Abstract: http://obroncology.com/imshealth/content/ESMO%202011_pPirolli_1669-A-2_v2%20copy.pdf
Condition Year Language Analysis type
, Hematology 2011 English , Retrospective database analysis
 
 
Iron deficiency anaemia and delayed diagnosis of colorectal cancer: a retrospective cohort study.
Authors: Damery S, Ryan R, Wilson S, Ismail T, Hobbs R.
Affiliations: 
Publications: 
Colorectal Dis. 2011 Apr;13(4):e53-60. doi: 10.1111/j.1463-1318.2010.02488.x.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21054747
Condition Year Language Analysis type
, Hematology, Oncology 2011 English
 
 
Rate of Hemoglobin Decline in Patients Receiving Chemotherapy without an Erythropoiesis-Stimulating Agent in the United States Community Setting
Authors: Pirolli M1, Collins H2, Quigley J1, Hulnick S1
Affiliations: 1 IMS Health, USA (Formerly SDI Health) 2 Amgen, Inc., Thousand Oaks, USA
Publications: 
European Journal of Cancer, 2011
Document Types: , Abstract
Countries: 
Abstract: http://obroncology.com/imshealth/content/ESMO%202011_pPirolli_1669-A-2_v2%20copy.pdf
Condition Year Language Analysis type
, Hematology 2011 English , Retrospective database analysis
 
 
Relation of the first hypertension-associated event with medication, compliance and persistence in naive hypertensive patients after initiating monotherapy
Authors: Mathes J1, Kostev K2, Gabriel A1, Pirk O1, Schmieder RE3
Affiliations: 1 IMS HEALTH GmbH & Co. OHG, Nuremberg 2 IMS HEALTH GmbH & Co. OHG, Frankfurt 3 Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital, Erlangen, Germany
Publications: 
Int J Clin Pharmacol Ther, 2010, Vol. 48, No. 3: S.173-183
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Hematology, Medication compliance 2010 English , Retrospective cohort analysis
 
 
Prozesskostenanalyse in der Thromboembolieprophylaxe nach elektiver Hüft- und Kniegelenkersatzoperation [Process cost analysis for the prophylaxis of thromboembolism after an elective artificial hip and knee joint replacement surgery]
Authors: Lipp H‐P1, Stemmer V2, Kogler C2, Narayanan S3, Eckhard P3
Affiliations: 1 Eberhard Karls University Tübingen, Tübingen, Germany 2 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany 3 Bayer Vital GmbH, Leverkusen, Germany
Publications: 
2nd annual conference of the Deutschen Gesellschaft für Gesundheitsökonomie (dggö) [German Association for Health Economics], Berlin, Germany, 1.-2.- March, 2010
Document Types: , Abstract
Countries: , Germany
Condition Year Language Analysis type
, Hematology 2010 German , Cost analysis
 
 
Treatment cost of hemophilia patients with inhibitors in the National Health System in Morocco
Authors: El Khorassani M, Hadjkhalifa H, By Z, Plun-Favreau J, Lindner L, Prior M.
Affiliations: 
Publications: 
Espérance Méd 2010; 17: 101-7.
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Hematology 2010 Spanish , Cost effectiveness
 
 
Verbrauch von Erythropoese-stimulierenden Faktoren in der Therapie der renalen Anämie: Analyse von Verordnungsdaten aus der Routineversorgung in Deutschland
Authors: Schöffski O1, Müller H-J2, Kostev K3, Claus V4
Affiliations: 1 Lehrstuhl für Gesundheitsmanagement Universität Erlangen-Nürnberg, Germany, 2 Medizinische Klinik III, Klinikum Fulda gAG, Germany, 3 IMS Health GmbH & Co. OHG, Munich, Germany, 4 IMS Health GmbH & Co. OHG, Frankfurt, Germany
Publications: 
Nieren- und Hochdruckkrankheiten; XX, 2010 (accepted)
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Hematology, Nephrology 2010 English , Retrospective cohort analysis
 
 
Cost-utility analysis of dasatinib as a second line treatment in the chronic phase of chronic myeloid leukaemia in Russia
Authors: Kuznetzov S1, Mungapen L2, Samyshkin Y2, Jakouloff D3, Sbarigia U4, van Baardewijk M4
Affiliations: 1 Haematology Research Centre, Moscow, Russia, 2 IMS Health, London, UK, 3 BMS, Moscow, Russia, 4 BMS, Braine L’Alleud, Belgium
Publications: 
ISPOR 13th Annual European Congress, 6-9 November 2010, Prague Congress Centre, Prague, Czech Republic.
Document Types: , Poster
Countries: , Russian Federation
Condition Year Language Analysis type
, Hematology, Oncology 2010 English , Cost utility
 
 
The economic consequences of ineffective inpatient on-demand treatment for haemophilia with inhibitors: a US retrospective data analysis.
Authors: Pokras SM1. Weatherall J2. Petrilla AA1. Lee WC1.
Affiliations: 1 IMS Health, Alexandria, US 2 Novo Nordisk
Publications: 
World Federation of Hemophilia Congress 2010, Buenos Aires, Argentina, July 2010
Document Types: , Abstract
Countries: , USA
Condition Year Language Analysis type
, Hematology 2010 English , Retrospective database analysis
 
 
Potential cost savings associated with faster bleeding resolution in the inpatient treatment of haemophilia with inhibitors.
Authors: Weatherall J1, Munakata J2, Lee WC2
Affiliations: 1 Novo Nordisk A/S, Soborg, Denmark 2 IMS Health, Falls Church VA, US
Publications: 
ISPOR 4th Asia-Pacific Conference, 2010, September 5-7, Phuket, Thailand
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Hematology 2010 English , Cost analysis
 
 
Optimizing treatment strategies for acute bleeds in haemophilia with inhibitors: long-term impact of early treatment decisions.
Authors: Munakata J1, Kowal S1, Weatherall J2, Lee WC1
Affiliations: 1 IMS Health, Falls Church, VA 2 Novo Nordisk A/S, Soborg, Denmark
Publications: 
The XXIX International Congress of the World Federation of Hemophilia, 2010, July 10-14, Buenos Aires, Argentina
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Hematology 2010 English , Economic evaluation
 
 
Medical cost savings associated with a reduced need for re-treatment and fewer infusions required per bleed in the management of on-demand bleeds in haemophilia patients with inhibitors.
Authors: Kowal S1, Munakata J1, Weatherall J2, Lee WC1
Affiliations: 1 IMS Health, Falls Church, VA 2 Novo Nordisk A/S, Soborg, Denmark
Publications: 
The XXIX International Congress of the World Federation of Hemophilia, 2010, July 10-14, Buenos Aires, Argentina
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Hematology 2010 English , Economic evaluation
 
 
Impact of faster bleeding resolution on health-related quality of life (HRQoL) and quality adjusted life years (QALYs) in haemophilia patients with inhibitors.
Authors: Kowal S1, Munakata J1, Weatherall J2, Lee WC1
Affiliations: 1 IMS Health, Falls Church, VA, US 2 Novo Nordisk A/S, Soborg, Denmark
Publications: 
The XXIX International Congress of the World Federation of Hemophilia, 2010, July 10-14, Buenos Aires, Argentina
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Hematology 2010 English , Economic evaluation
 
 
Effect of Reimbursement Changes on Erythropoiesis-Stimulating Agent Utilization and Transfusions
Authors: Hess, G., Nordyke, R. J., Hill, J., Hulnick, S.
Affiliations: 
Publications: 
American Journal of Hematology
Document Types: , Abstract
Countries: , USA
Condition Year Language Analysis type
, Hematology 2010 English , Retrospective database analysis
 
 
Iron deficiency anaemia and delayed diagnosis of colorectal cancer: a retrospective cohort study
Authors: Damery S, Ryan R, Wilson S, Ismail T & Hobbs FR
Affiliations: Primary Care Clinical Sciences, School of Health and Population Sciences, University of Birmingham
Publications: 
Colorectal Disease doi: 10.1111/j.1463-1318.2010.02488.x
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Hematology 2010 English , Retrospective database analysis
 
 
[Coste-efectividad de la identificación genética en pacientes en tratamiento con acenocumarol] Genotyping in patients in treatment with acenocumarol cost-effectiveness.
Authors: Lindner L, Lara N, Tàssies D, Tejedor D, Jofre-Monseny L
Affiliations: Lindner L1, Lara N1, Tàssies D2, Tejedor D3, Jofre-Monseny L3. 1Health Economics & Outcomes Research - IMS Health; 2Servicio de Hemoterapia y Hemostasia.Hospital Clínic Barcelona. 3 Progenika Biopharma S.A
Publications: 
Document Types: , Article, Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Health economics, Hematology 2009 Spanish , Cost effectiveness
 
 
Cost Study of Haemophilia in Morocco
Authors: Plun-Favreau J1, By Z2, Lindner L3, Prior M3
Affiliations: 1Novo Nordisk Pharma S.A.S., Zurich Oerlikon, Switzerland, 2Novo Nordisk Pharma S.A.S., Casablanca, Morocco, 3IMS Health, Barcelona, Spain
Publications: 
ISPOR 12th Annual European Congress 2009, 24 to 27 October, Paris, France
Document Types: , Oral presentation
Countries: 
Condition Year Language Analysis type
, Hematology 2009 English , Cost analysis
 
 
Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain.
Authors: Mayordomo JI, López A, Viñolas N, Castellanos J, Pernas S, Domingo Alonso J, Frau A, Layola M, Antonio Gasquet J, Sánchez J; ENIA Study Group.
Affiliations: 1 Clínico Lozano Blesa, Zaragoza, Spain 2 Vall d’Hebron, Barcelona, Spain 3 Clínic i Provincial, Barcelona, Spain 4 Xeral-Cíes, Vigo, Spain 5 Institut Català d’Oncologia, L’Hospitalet-Barcelona, Spain 6 Virgen de la Arrixaca, Murcia, Spain 7 Provincial de Castellón, Castellón, Spain 8 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain 9 Amgen S.A., Barcelona, Spain
Publications: 
Curr Med Res Opin. 2009 Oct;25(10): 2533-42.
Document Types: , Article
Countries: , Spain
Abstract: http://informahealthcare.com/doi/abs/10.1185/03007990903209563
Condition Year Language Analysis type
, Hematology, Oncology 2009 English ,
 
 
Verbrauch von Erythropoese-stimulierenden Faktoren in der Therapie der renalen Anämie - eine „real life“- Analyse der Versorgungssituation in Deutschland [Consumption of erythropoietin-stimulating factors in the renal anaemia therapy - a "real life"-analysis of the German medical treatment situation]
Authors: Schöffski O1, Müller H-J2, Kostev K3, Claus V4
Affiliations: 1 University Erlangen-Nuremberg, Nuremberg, Germany 2 Med. Klinik III Klinikum Fulda gAG, Fulda, Germany 3 IMS Health, Frankfurt, Germany 4 IMS Health, Munich, Germany
Publications: 
Congress for nephrology, Göttingen, Germany, 26-29 September 2009
Document Types: , Abstract, Poster
Countries: , Germany
Condition Year Language Analysis type
, Health economics, Hematology, Nephrology 2009 German , Retrospective database analysis
 
 
Trajectory of Hemoglobin (Hb) in Patients Receiving Erythropoiesis-Stimulating Agents (ESAs) for Anemia Due to Concomitantly Administered Myelosuppressive Chemotherapy (CIA)
Authors: Hill J1, Cong Z2, Hess G1, Nordyke R2
Affiliations: 1IMS Health, Former SDI, Plymouth Meeting, PA 2Global Health Economics, Amgen Inc., Thousand Oaks, CA
Publications: 
American Society of Hematology December 5, 2009
Document Types: , Poster
Countries: 
Abstract: https://ash.confex.com/ash/2009/webprogram/Paper24805.html
Condition Year Language Analysis type
, Hematology 2009 English
 
 
The importance of clinical variables in comparative analyses using propensity-score matching: the case of ESA costs for the treatment of chemotherapy-induced anaemia.
Authors: Polsky D1, Eremina D2, Hess G12, Hill J2, Hulnick S2, Roumm A2, Whyte JL3, Kallich J3
Affiliations: 1University of Pennsylvania, Philadelphia, PA, USA, 2IMS Health (Former SDI Health),Plymouth Meeting, PA, USA, 3Amgen Inc., Thousand Oaks, California, USA
Publications: 
Pharmacoeconomics. 2009;27(9):755-65
Document Types: , Article
Countries: 
Abstract: http://link.springer.com/article/10.2165%2F11313860-000000000-00000
Condition Year Language Analysis type
, Health economics, Hematology 2009 English , Cost analysis, Cost effectiveness, Quality of life
 
 
Erythropoiesis stimulating agent (ESA) administration at Hb <10 g/dL for chemotherapy-induced anemia (CIA) following the National Coverage Decision (NCD)
Authors: Hulnick SA, Hess G, Hill J, Viswanathan HN, Nordyke RJ
Affiliations: IMS Health, (Former Surveillance Data, Inc.), Plymouth Meeting, PA; Leonard Davis Institute, University of Pennsylvania, Plymouth Meeting, PA; Amgen, Inc., Thousand Oaks, CA
Publications: 
J Clin Oncol 27, 2009 (suppl; abstr e20627)
Document Types: , Abstract
Countries: 
Abstract: http://meetinglibrary.asco.org/content/35272-65
Condition Year Language Analysis type
, Hematology 2009 English , Burden of illness, Quality of life, Retrospective cohort analysis
 
 
Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom.
Authors: Arellano FM, Arana A, Wentworth CE, Fernández-Vidaurre C, Schlienger RG & Conde E
Affiliations: Risk MR, LLC, Bridgewater, NJ, USA
Publications: 
J Allergy Clin Immunol. 2009 May;123(5):1111-6, 116.e1-13. doi: 10.1016/j.jaci.2009.02.028. Epub 2009 Apr 10.
Document Types: , Abstract
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19361841
Condition Year Language Analysis type
, Dermatology, Hematology, Oncology 2009 English , Retrospective database analysis
 
 
The incidence of and mortality from leukaemias in the UK: a general population-based study
Authors: Bhayat F, Das-Gupta E, Smith C, McKeever T & Hubbard R
Affiliations: Division of Epidemiology and Public Health, University of Nottingham
Publications: 
BMC Cancer 2009, 9:252
Document Types: , Abstract
Countries: , UK
Abstract: http://www.biomedcentral.com/1471-2407/9/252
Condition Year Language Analysis type
, Hematology, Oncology 2009 English , Retrospective database analysis
 
 
Impact de la mise sur le marché d’une nouvelle érythropoïétine à injection mensuelle en termes de gain de temps et d’optimisation organisationnelle pour les personnels impliqués dans le circuit de l’EPO dans les centres d’hémodialyse.
Authors: Allard B., Grégoire M., Ferrandini C., Ollivier C., Vrtovsnik F., Zambrowski JJ., Mouradian A.
Affiliations: 
Publications: 
les Journées Annuelles de la Société de Néphrologie et de la Société francophone de dialyse ». 26-29 novembre 2008
Document Types: , Abstract, Oral presentation
Countries: , France
Condition Year Language Analysis type
, Hematology 2008 French , Survey research
 
 
Assessment of the benefits of time savings achieved by once monthly injection of erythropoietin stimulating agents (ESA) on anaemia management in haemodialysis centres
Authors: Allard B., Grégoire M., Ferrandini C., Ollivier C., Vrtovsnik F., Zambrowski JJ., Lamure E, Baillon N
Affiliations: 
Publications: 
ISPOR congress. 8-11 November 2008
Document Types: , Abstract, Oral presentation
Countries: , France
Condition Year Language Analysis type
, Hematology 2008 English , Survey research
 
 
Health and Economic Consequences of Pathogen Transmission Risk in the Treatment of Haemophilia A with Factor Viii
Authors: Asukai Y1, Lloyd AC1, Ghatnekar O2, Hutchings AS3
Affiliations: 1 IMS Health, London, UK 2 The Swedish Institute for Health Economics, Lund, Sweden 3 Baxter Healthcare, Newbury, UK
Publications: 
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11, 2008.
Document Types: , Oral presentation
Countries: , UK
Condition Year Language Analysis type
, Hematology 2008 English , Burden of illness
 
 
Epidemiology of idiopathic thrombocytopenic purpura in Belgium assessed using hospital records.
Authors: Gerlier L1, De Vos C1, Lamotte M1, Malfait M2, Poitrinal P3
Affiliations: 1 IMS Health, Brussels, Belgium 2 Amgen, Brussels, Belgium 3 Amgen, Zug, Switzerland
Publications: 
ISPOR 11th Annual International Meeting, 2008, November 8-11, Athens, Greece
Document Types: , Abstract
Countries: , Belgium
Condition Year Language Analysis type
, Hematology 2008 English , Epidemiological study
 
 
A health economic evaluation of the use of erythropoiesis-stimulating agents (ESA) in patients with renal failure treated with haemodialysis.
Authors: Van Bellinghen LA1, Lamotte M1, Malfait M2
Affiliations: 1 IMS Health, Brussels, Belgium 2 Amgen, Brussels, Belgium
Publications: 
ISPOR 11th Annual International Meeting, 2008, November 8-11, Athens, Greece
Document Types: , Abstract
Countries: , Belgium
Condition Year Language Analysis type
, Hematology 2008 English , Economic evaluation
 
 
Cost-effectiveness of enoxaparin as prophylactic therapy versus unfractionated heparin or no prophylaxis in hospitalised medical patients
Authors: Feng J, Yuen C, Jackson D
Affiliations: 
Publications: 
ISPOR 11th Annual European Congress 8–11 November 2008 Athens Greece
ISPOR 11th Annual European Congress, Athens Greece. November 2008
Document Types: , Oral presentation, Poster
Countries: 
Condition Year Language Analysis type
, Hematology, Vascular disease 2008 English , Cost effectiveness
 
 
Myelodysplastic Syndromes: Aspects of current medical care and economic considerations in Germany
Authors: Gattermann N 1, Hofmann WK 2, Meeßen A 3, Schmitz S 4, Tsamaloukas A 5, Vollmer T 6, Wedding U 7, Plesnila-Frank C 8, Schramm W 9, Berger K 8
Affiliations: 1 Universitätsklinukum Düsseldorf,Germany 2 Charité Campus Benjamin Franklin, Berlin, Germany 3 Verband der Angestellten-Krankenkassen e.V. / Arbeiter-Ersatzkassen-Verband e.V., Siegburg, Germany 4 Hämatologe/Onkologe, Cologne, Germany 5 Internist/Onkologe, Hilden, Germany 6 Psycho-Onkologin, Rotterdam, Netherlands 7 Universitätsklinikum Jena, Germany 8 IMS Health, Munich, Germany 9 Klinikum der Universität München, Munich, Germany
Publications: 
Onkologie 2008; 31: 477-84.
Document Types: , Article
Countries: , Germany
Abstract: http://content.karger.com/produktedb/produkte.asp?doi=142900
Condition Year Language Analysis type
, Hematology 2008 English , Workshop
 
 
The importance of anaemia in diagnosing colorectal cancer: a case-control study using electronic primary care records.
Authors: Hamilton W, Lancashire R, Sharp D, Peters T J, Cheng K & Marshall T
Affiliations: Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol
Publications: 
Br J Cancer. 2008 Jan 29;98(2):323-7. doi: 10.1038/sj.bjc.6604165. Epub 2008 Jan 22.
Document Types: , Abstract
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18219289
Condition Year Language Analysis type
, Hematology, Oncology 2008 English , Retrospective database analysis
 
 
Cost-Effectiveness of Rivaroxaban versus Enoxaparin for Thromboprophylaxis after total hip replacement in Spain.
Authors: Diamantopoulos A1, Forster F1, Brosa M2, Lees M3, Piñol C4, Febrer L4
Affiliations: 1IMS Health, London, UK, 2Oblikue Consulting, Barcelona, Spain, 3Bayer HealthCare, Uxbridge, UK, 4Bayer HealthCare, Barcelona, Spain
Publications: 
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11,
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Hematology 2007 English , Cost effectiveness
 
 
Cost-Effectiveness of Rivaroxaban versus Enoxaparin for Thromboprophylaxis after total hip replacement in the UK.
Authors: Diamantopoulos A1, Forster F1, Lees M2, Gilmour L3, Ashley D4
Affiliations: 1IMS Health, London, UK, 2Bayer HealthCare, Uxbridge, UK, 3Bayer Healthcare Pharmaceuticals Inc, Newbury, Berkshire, UK, 4Bayer Healthcare Pharmaceuticals Inc, Newbury, UK
Publications: 
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11,2008
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Hematology 2007 English , Cost effectiveness
 
 
Prophylaxis with Rivaroxaban against Venous Thromboembolism (VTE): A Cost-Consequence Analysis from the perspective of the Italian Healthcare Service.
Authors: Negrini C1, Diamantopoulos A2, Forster F2, Lopatriello S3, Lees M4, Bianchi C5, Pedone MP5
Affiliations: 1PBE Consulting, Milano, Italy, 2IMS Health, London, UK, 3Pbe Consulting, Verona, Italy, 4Bayer HealthCare, Uxbridge, UK, 5Bayer HealthCare, Milan, Italy
Publications: 
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11, 2008
Document Types: , Poster
Countries: , Italy
Condition Year Language Analysis type
, Hematology 2007 English , Cost consequence
 
 
Assesment of the economic value of the INTERCEPT blood system in Belgium.
Authors: Moeremans K, Warie H, Annemans L
Affiliations: 
Publications: 
Transfus Med.; 16:17-30
Document Types: , Manuscript in preparation
Countries: , Belgium
Condition Year Language Analysis type
, Hematology 2006 English
 
 
Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting
Authors: Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R & Vallance P
Affiliations: Department of Epidemiology, London School of Hygiene and Tropical Medicine
Publications: 
Lancet. 2006 Apr 1;367(9516):1075-9.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/16581406
Condition Year Language Analysis type
, Hematology, Respiratory disease 2006 English , Retrospective database analysis
 
 
Copyright 2024 IMS Health Incorporated. All rights reserved.